Concepedia

Joerg Bruenke

JB

Statistics

Publications

7

Citations

361

H-Index

7

Active since

2004

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

University Children's Hospital Tübingen

Universitätsklinikum Erlangen

Christian-Albrechts-Universität zu Kiel

Joerg Bruenke is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, antibody engineering, and cell biology.

ORCID

Top concepts

Publications per year

2004–2016

7

Publications

7

A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells

Christian Kellner, Joerg Bruenke, Julia Stieglmaier et al. · Journal of Immunotherapy · 2008 · 77 citations

, , +15

Effective lysis of lymphoma cells with a stabilised bispecific single‐chain Fv antibody against CD19 and Fc<i>γ</i>RIII (CD16)

Joerg Bruenke, Karin Barbin, Susanne Kunert et al. · British Journal of Haematology · 2005 · 59 citations · Full text

A recombinant bispecific single‐chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells

Joerg Bruenke, Barbara Fischer, Karin Barbin et al. · British Journal of Haematology · 2004 · 50 citations · Full text

Quantitative Comparison of the Antimicrobial Efficiency of Leaching versus Nonleaching Polymer Materials

Joerg Bruenke, Ingolf Roschke, Seema Agarwal et al. · Macromolecular Bioscience · 2016 · 47 citations · Full text

, , +12

Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells

Christian Kellner, Joerg Bruenke, Heike Horner et al. · Cancer Letters · 2011 · 44 citations

, , +6

1–5 of 7